
CVKD
Cadrenal Therapeutics
$2.06
+$0.02 (+0.98%)Jul 27, 2026
Key metrics
The numbers that frame CVKD today
- Market cap
- $5.91M
- P/E (TTM)
- -0.5
- EV / FCF
- -0.3
- ROIC
- 1,138.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.86
- 52wk High
- $14.64
Growth
Revenue and earnings trend for CVKD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CVKD
Is Cadrenal Therapeutics a good buy?
No. Cadrenal Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Cadrenal Therapeutics is selling at a very high price.
What is the market capitalization of CVKD?
Cadrenal Therapeutics's market capitalization is $5.91M.
What is the P/E ratio for CVKD stock?
Cadrenal Therapeutics's current P/E ratio is -0.5.
What is the 52-week high for CVKD stock?
The 52-week high for Cadrenal Therapeutics is $14.64. The current close of $2.06 is 85.9% below that high.
What is the 52-week low for CVKD stock?
The 52-week low for Cadrenal Therapeutics is $1.86. The current close of $2.06 is 10.8% above that low.
Does CVKD stock pay dividends?
Cadrenal Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CVKD?
Cadrenal Therapeutics's Debt / Equity ratio is 0.